Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HealthTronics and Endocare complete merger

This article was originally published in The Gray Sheet

Executive Summary

Urology service provider completes the previously-announced $16 million acquisition of cryoablation device-maker Endocare with the close of its exchange offer for all outstanding shares of Endocare's common stock, announced July 27 (1"The Gray Sheet" June 15, 2009). Endocare's main product is the Cryocare cryosurgery system, indicated for general surgery, urology, gynecology and oncology, among other procedures. The firm will be a wholly-owned subsidiary of Austin, Texas-based HealthTronics

You may also be interested in...



HealthTronics snags Endocare

Urology service provider and device distributor HealthTronics acquires prostate cancer cryoablation device developer Endocare for $16 million in cash and stock. Under a definitive agreement announced June 8, HealthTronics will pay $1.35 for each of Endocare's 11.8 million outstanding common stock shares - a 50% premium over the stock's previous close of $0.90 on June 5. While HealthTronics had offered $2.28 per share for Endocare last summer, Endocare rejected the unsolicited bid in favor of a November merger deal with Galil Medical (1"The Gray Sheet" Aug. 18, 2008, In Brief). But the Galil deal fell through when the closing conditions could not be met (2"The Gray Sheet" Nov. 17, 2008, p. 4). Endocare's main product is the Cryocare cryosurgery system, indicated for general surgery, urology, gynecology and oncology, among other procedures. HealthTronics says the deal will "solidify its position as the leading provider of products and services to the urology community.

Dr Reddy's Adds To OTC Portfolio With Glenmark Deal

Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.

Sandoz Launches US Awareness Campaign

Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.

Topics

UsernamePublicRestriction

Register

LL026487

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel